Mutagenicity testing of β-asarone and commercial calamus drugs with Salmonella typhimurium

Mutation Research Letters

Volumn 121, Issue 3-4, 1983, Pages 191-194

  Göggelmann, Waltraud ^a,b   Schimmer, Oskar ^a,b  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ASARONE;

CALAMUS; CHEMICAL MUTAGENESIS; DRUG SCREENING; HEREDITY; IN VITRO STUDY; MUTAGENICITY; NONHUMAN; S 9 MIX; SALMONELLA TYPHIMURIUM;

ANIMAL; ANISOLES; MALE; MUTAGENICITY TESTS; PLANT EXTRACTS; PLANTS, MEDICINAL; RATS; RATS, INBRED STRAINS;

EID: 0020576244     PISSN: 01657992     EISSN: None     Source Type: Journal    
DOI: 10.1016/0165-7992(83)90202-6     Document Type: Article

References (9)

1. Zur Zytologie, geographischen Verbreitung und Morphologie des Kalmus
2. On the different β-asarone contents of commercial calamus drugs
3. Toxicity of oil of calamus (Jammu variety)
4. Carcinogenicity of oil of calamus
5. Project P-155-70
6. Methods for detecting carcinogens and mutagens with the Salmonella/mammalian-microsome mutagenicity test
7. Mutagenicity screening of crude drugs with Bacillus subtilis rec-assay and Salmonella/microsome reversion assay
8. Mutagenic activities of gentisin and isogentisin from Gentianae radix (Gentianaceae)